We’ve assembled a truly scalable platform around the radically advanced design of G-Rex® closed-system bioreactors.
G-Rex reimagines 100 years of cell culture assumptions to make cell therapy manufacturing straightforward and efficient.
Straightforward, reproducible scale up: G-Rex bioreactors scale from 10 million to 100 billion cells in escalating G-Rex sizes.
G-Rex®6M Well Plate
Yield: 200-400x106 cells/well
G-Rex®10M Series
Yield: 200-400x106 cells
G-Rex®100M Series
Yield: 2-4x109 cells
G-Rex®500M Series
Yield: 10-20x109 cells
Get more processing power in less space using G-Rex bioreactors.
The ScaleReady platform is an immediate solution for high throughput manufacturing. By combining G-Rex bioreactors with efficient cell processing instruments, our platform will process multiple cell therapy products in a day within a small cubic footprint. This allows you to create commercially viable process that can grow with future demand.
Quality-driven reagents and media, and speedy, cost-efficient gene editing systems.
Simplify your cell and gene therapy workflow with all the ancillary reagents and media needed, as well as the TcBuster™ non-viral delivery platform for faster, more cost-efficient gene editing.
See Reagents and Media >See Gene Editing Products >
Increase your manufacturing power with high-throughput, closed-system cell processing.
The highly flexible Lovo® cell processing system eliminates manual steps involved in preparing cells for immunomagnetic selection. The Cue cell processing system is the definitive instrument for fill and finish. Both high-throughput instruments from Fresenius Kabi can process cells from multiple G-Rex bioreactors.
Refer to the LOVO Cell Processing System Operator’s Manual and Cue Cell Processing System User’s Guide for a complete list of warnings and precautions associated with the use of these products.
See how everything is used together in the ScaleReady™ workflow.
The Lovo Cell Processing System and Cue Cell Processing System are for laboratory use and may not be used for direct transfusion. Appropriate regulatory clearance is required by the user for clinical use. Refer to the Lovo Cell Processing System Operator’s Manual and Cue Cell Processing System User’s Guide for a complete list of warnings and precautions associated with the use of these products.